Nebuliser, inhaler demand for children jumps by up to 60 pc in Delhi winters: Survey

New Delhi:  The demand for nebulisers, inhalers and respiratory medicines for children has surged sharply in Delhi during winter months, with chemists reporting spikes of up to 60 per cent during periods of severe air pollution, a survey has found out.

Nearly one-third of all nebuliser purchases were for children, reflecting the growing respiratory distress among younger age groups amid worsening air quality, the survey report noted.

The comprehensive survey was carried out by ‘Warrior Moms’ in collaboration with chemists in south, east, north and central Delhi last year, followed by a re-run with more pharmacists this year.

Chemists reported that sales of commonly prescribed asthma and respiratory medicines such as Asthalin, Levolin, Budecort and Seroflo rose significantly between November and January, when pollution levels typically peak.

In north Delhi alone, sales of some inhalers increased by about 40 per cent, while central and south Delhi outlets recorded a 50 to 60 per cent jump in demand for nebulisers.

Parents frequently complained of symptoms such as persistent cough, wheezing, breathlessness and chest tightness in children, with many chemists noting that these problems worsened during high-smog periods, especially in the early mornings and evenings, the survey said.

The report also highlighted supply challenges, with several pharmacies struggling to maintain stocks of high-demand items like Duolin Respules and Budecort nebulising solutions during peak pollution months.

Calling the findings a public health warning, the survey recommended advance stocking of respiratory aids, improved supply chain management and greater public awareness, particularly in schools, to help parents and children cope with pollution-related respiratory illnesses during Delhi’s winter season.

Related Posts

WHO launches new primary health care course to strengthen health systems globally

Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

WHO launches new primary health care course to strengthen health systems globally

WHO launches new primary health care course to strengthen health systems globally

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert